70121-1755
ALYMSYS
bevacizumab-maly
INJECTION, SOLUTION
Intravenous
BEVACIZUMAB
400.0
mg/16mL
70121-1755-07
10 VIAL in 1 CARTON (70121-1755-7) > 16 mL in 1 VIAL
April 15, 2022
Immunotherapy
Monoclonal Antibody
VEGF
 
 
In Use